Access to 18F‐labelled isoxazoles by ruthenium‐promoted 1,3‐dipolar cycloaddition of 4‐[18F]fluoro‐N hydroxybenzimidoyl chloride with alkynes

Loading...
Thumbnail Image

Full text at PDC

Publication date

2019

Advisors (or tutors)

Editors

Journal Title

Journal ISSN

Volume Title

Publisher

Citations
Google Scholar

Citation

Roscales S, Kniess T. Access to18 F ‐labelled isoxazoles by ruthenium‐promoted 1,3‐dipolar cycloaddition of 4‐[18 F ]fluoro‐ N ‐hydroxybenzimidoyl chloride with alkynes. Labelled Comp Radiopharmac [Internet]. 30 de junio de 2019 [citado 25 de noviembre de 2025];62(8):393-403. Disponible en: https://analyticalsciencejournals.onlinelibrary.wiley.com/doi/10.1002/jlcr.3708

Abstract

4‐[18F]Fluoro‐N‐hydroxybenzimidoyl chloride (18FBIC), an 18F‐labelled aromatic nitrile oxide, was developed as building block for Ru‐promoted 1,3 dipolar cycloaddition with alkynes. 18FBIC is obtained in a one‐pot synthesis in up to 84% radiochemical yield (RCY) starting from [18F]fluoride with 4‐[18F]fluorobenzaldehyde (18FBA) and 4-[18F]fluorobenzaldehyde oxime (18FBAO) as intermediates, by reaction of 18FBAO with N‐chlorosuccinimide (NCS). 18FBIC was found to be a suitable and stable synthon to give access to 18F‐labelled 3,4‐diarylsubstituted isoxazoles by [Cp*RuCl(cod)]‐catalysed 1,3‐dipolar cycloaddition with various alkynes. So the radiosynthesis of a fluorine‐18–labelled COX‐2 inhibitor [18F]1b, a close derivative of valdecoxib, was performed with 18FBIC and 1‐ethynyl‐4‐(methylsulfonyl)benzene, providing [18F]1b in up to 40% RCY after purification in 85 minutes. The application of 18FBIC as a building block in the synthesis of 18F‐labelled heterocycles will generally extend the portfolio of available PET radiotracers.

Research Projects

Organizational Units

Journal Issue

Description

Keywords

Collections